Amylyx Pharmaceuticals, Inc.(AMLX:US)
Market Cap$2.933B
Key Metrics
Price$26.34
Revenue (TTM)$0
Holders Revenue (TTM)-
Gross Profit (TTM)$0
Earnings (TTM)-$152.09M
EBITDA (TTM)-$161.74M
Op. Margin (TTM)-
Dividend Yield-
Holders Yield-
Cash on hand$49.33M
Total Assets$264.56M
Net Assets$239.17M
Total Debt$5.26M
Key Metrics
Price$26.34
Revenue (TTM)$0
Holders Revenue (TTM)-
Gross Profit (TTM)$0
Earnings (TTM)-$152.09M
EBITDA (TTM)-$161.74M
Op. Margin (TTM)-
Dividend Yield-
Holders Yield-
Cash on hand$49.33M
Total Assets$264.56M
Net Assets$239.17M
Total Debt$5.26M
Financials
| Name | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 | $0 | - | - | - | - | - | - | - | $98.22M | $71.43M | $21.89M | $345K | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
Cost of Revenue | - | $0 | $0 | $0 | $0 | - | - | - | - | - | - | - | $5.58M | $5.28M | $2.82M | $172K | $0 | $0 | - | $0 | - | - | - |
Gross Profit | - | $0 | $0 | $0 | $0 | - | - | - | - | - | - | - | $92.64M | $66.15M | $19.06M | $173K | $0 | $0 | - | $0 | - | - | - |
| $45.69M | $43.78M | $36.61M | $36.03M | $42.86M | - | - | - | - | - | - | - | $72.44M | $68.2M | $63.66M | $54.85M | $54.25M | $47.81M | $28.32M | $22.92M | $18.59M | $12.87M | $8.59M | |
| Research and Development | $23.77M | $27.61M | $21.21M | $19.86M | $27.22M | - | - | - | - | - | - | - | $29.04M | $24.19M | $22.81M | $24.91M | $24.26M | $21.46M | $13.39M | $12.85M | $10.93M | $6.86M | $5.01M |
| Selling, General, and Administrative | $21.93M | $16.17M | $15.39M | $16.17M | $15.64M | - | - | - | - | - | - | - | $43.39M | $44.01M | $40.84M | $29.94M | $29.99M | $26.35M | $14.92M | $10.35M | $7.66M | $6M | $3.93M |
| Other Operating Expenses | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $0 | -$285K | - | - | -$350K |
Operating Income | -$45.69M | -$43.78M | -$36.61M | -$36.03M | -$42.86M | -$37.8M | -$40.65M | -$39.46M | -$53.44M | -$122.13M | $1.93M | $18.72M | $20.2M | -$2.05M | -$44.59M | -$54.68M | -$54.25M | -$47.81M | -$28.32M | -$22.92M | -$18.59M | -$12.87M | -$8.59M |
| $2.27M | $2.5M | $3.65M | $1.64M | $1.41M | - | - | - | - | - | - | - | $3.81M | $3.46M | $2.47M | $800K | $360K | $112K | -$29K | -$224K | -$3.34M | -$1.66M | $0 | |
| Non-Operating Interest Income | $2.32M | $2.57M | $3.29M | $1.82M | $1.96M | - | - | - | - | - | - | - | $3.89M | $3.72M | $3.16M | $601K | $402K | $131K | $30K | $3K | $1K | $2K | $0 |
| Non-Operating Interest Expense | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $0 | - | - | - | $1K |
| Other Income/Expense | -$53K | -$75K | $362K | -$180K | -$546K | - | - | - | - | - | - | - | -$81K | -$262K | -$689K | $199K | -$42K | -$19K | -$59K | -$227K | -$3.34M | -$1.66M | $1K |
Income Before Tax | -$43.42M | -$41.28M | -$32.95M | -$34.39M | -$41.44M | - | - | - | - | - | - | - | $24.01M | $1.4M | -$42.13M | -$53.88M | -$53.89M | -$47.7M | -$28.34M | -$23.14M | -$21.92M | -$14.52M | -$8.59M |
Income Tax | - | - | $46K | $0 | $0 | - | - | - | - | - | - | - | $1.93M | -$170K | $579K | -$125K | $174K | $146K | - | $0 | $0 | $0 | - |
Net Income | -$43.42M | -$41.28M | -$33M | -$34.39M | -$41.44M | - | - | - | - | - | - | - | $22.07M | $1.57M | -$42.7M | -$53.76M | -$54.07M | -$47.85M | -$28.34M | -$23.14M | -$21.92M | -$14.52M | -$8.59M |
Minority Interests | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Preferred Stock Dividends | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Net Income to Common | -$43.42M | -$41.28M | -$33M | -$34.39M | -$41.44M | - | - | - | - | - | - | - | $22.07M | $1.57M | -$42.7M | -$53.76M | -$54.07M | -$47.85M | -$28.34M | -$23.14M | -$21.92M | -$14.52M | -$8.59M |
Shares Outstanding (Basic) | 111.2M | 110.56M | 109.84M | 93.33M | 89.14M | 85.7M | 68.59M | 68.09M | 68.02M | 67.85M | 67.41M | 67.41M | 67.23M | 66.72M | 65.42M | 58.53M | 58.28M | 51.6M | - | 55.22M | 45.95M | 45.95M | - |
Shares Outstanding (Diluted) | 111.2M | 110.56M | 109.84M | 93.33M | 89.14M | 85.7M | 68.59M | 68.09M | 68.02M | 67.85M | 69.2M | 69.75M | 70.13M | 70.86M | 65.42M | 58.53M | 58.28M | 51.6M | - | 55.22M | 45.95M | 45.95M | - |
EPS (Basic) | -$0.39 | -$0.37 | -$0.30 | -$0.37 | -$0.46 | -$0.42 | -$0.55 | -$1.07 | -$1.07 | -$1.75 | $0.07 | $0.31 | $0.33 | $0.02 | -$0.65 | -$0.92 | -$0.93 | -$0.93 | - | -$0.42 | -$0.48 | -$0.32 | - |
EPS (Diluted) | -$0.39 | -$0.37 | -$0.30 | -$0.37 | -$0.46 | -$0.42 | -$0.55 | -$1.07 | -$1.07 | -$1.75 | $0.07 | $0.30 | $0.31 | $0.02 | -$0.65 | -$0.92 | -$0.93 | -$0.93 | - | -$0.42 | -$0.48 | -$0.32 | - |
EBIT | -$45.69M | -$43.78M | -$36.61M | -$36.03M | -$42.86M | - | - | - | - | - | - | - | $20.2M | -$2.05M | -$44.59M | -$54.68M | -$54.25M | -$47.81M | -$28.34M | -$22.92M | -$18.59M | -$12.87M | -$8.59M |
EBITDA | -$45.65M | -$43.68M | -$36.5M | -$35.91M | -$42.72M | - | - | - | - | - | - | - | $20.48M | -$1.85M | -$44.41M | -$54.52M | -$54.15M | -$47.78M | -$28.32M | -$22.91M | -$18.58M | -$12.86M | -$8.59M |